Evidence map›Paper›PMID 41132837›Full record

ReviewActa pharmaceutica Sinica. B2025

New insights into translational research in Alzheimer's disease guided by artificial intelligence, computational and systems biology.

Shulan Jiang, Zixi Tian, Yuchen Yang, Xiang Li, Feiyan Zhou, Jianhua Cheng, Jihui Lyu, Tingting Gao, Ping Zhang, Hongbin Han and 1 more

Abstract readReview
PubMed Full text at PMC Publisher
In one paragraph

Review in Acta pharmaceutica Sinica. B, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Review
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Shulan JiangBeijing Geriatric Hospital, Beijing 100095, China.
Zixi TianBeijing Geriatric Hospital, Beijing 100095, China.
Yuchen YangBeijing Geriatric Hospital, Beijing 100095, China.
Xiang LiBeijing Geriatric Hospital, Beijing 100095, China.
Feiyan ZhouBeijing Geriatric Hospital, Beijing 100095, China.
Jianhua ChengDepartment of Neurology, the First Affiliated Hospital of Wenzhou Medical University, Wenzhou 325035, China.
Jihui LyuBeijing Geriatric Hospital, Beijing 100095, China.
Tingting GaoBeijing Geriatric Hospital, Beijing 100095, China.
Ping ZhangBeijing Geriatric Hospital, Beijing 100095, China.
Hongbin HanDepartment of Radiology, Peking University Third Hospital, Key Laboratory of Magnetic Resonance Imaging Equipment and Technique, NMPA Key Laboratory for Evaluation of Medical Imaging Equipment and Technique, Institute of Medical Technology, Peking University Health Science Center, Beijing 100191, China.
Zhiqian TongBeijing Geriatric Hospital, Beijing 100095, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Alzheimer's disease (AD) is characterized by cognitive and functional deterioration, with pathological features such as amyloid-beta (A

Indexed as

Alzheimer's diseaseArtificial intelligenceBig biomedical data miningComputational biologyDeep learningDrug developmentMachine learningSystems biology

Identifiers

PMID41132837
PMCPMC12541637

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.